Observer-blind, post-marketing study to compare the safety and immunogenicity of Fluviral trivalent split virion influenza vaccine (2007-2008 season) made with new vs. aged bulk material, in adults ranging in age from 18 to 60 years.
Latest Information Update: 03 Sep 2023
Price :
$35 *
At a glance
- Drugs GSK 1536489A (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline; GSK
- 21 Apr 2010 Actual number of patients added to 1000 as reported by ClinicalTrials.gov.
- 25 Jan 2008 New trial record.